Deep learning / AI meets biology and chemistry. I am focused on products that accelerate breakthroughs in biological sciences that allow for new products that help peoples lives through huge advancements in health. An example investment we have made is in Freenome.
Not Interested In
Not interested in anything outside of this area. Not interested in digital health that involves behavior modification programs.
George Zachary serves as General Partner at Charles River Ventures. He is also a Board Member of CoTap and Crushpath. Zachary led the Nintendo 64 development business at Silicon Graphics, managed sales and marketing for virtual reality pioneer VPL Research, and served as a product marketer at CATS Software. He is on the board of Stanford SSE, Stanford's StartX and is an advisor to the X PRIZE Foundation. Zachary earned a joint BS from MIT and MIT Sloan.
Ullas Naik
Investing in Software (Web Marketplace Saas..) &b...
Ullas Naik is the Founder and serves as General Partner at Streamlined Ventures. Naik founded Streamlined Ventures with a vision of building a thought leading investment platform rooted in the philosophical belief that founders of companies are the true heroes of entrepreneurial value creation in our society. Streamlined Ventures invests in and supports visionary founders working on transformational application and business infrastructure software companies for the Mobile Web, Social Web, Web and Enterprise markets. Ullas is a seasoned venture capitalist, angel investor and entrepreneur with over two decades of entrepreneurial and early stage investment experience across 300 companies. Prior to founding Streamlined Ventures, he co-founded investment firm Cota Capital. Prior to that, Ullas was a senior member of the investment team for 12 years at Globespan Capital and helped build the firm. He has also been an active angel investor over the last 21 years during which he invested in over 60 companies spanning Internet 1.0, Web 2.0, mobile web, social web, enterprise computing as well as disruptive technologies in other domains such as robotics and wearable computing. Before his institutional investing career Ullas was a top ranked Wall Street research analyst at FAC Equities/First Albany. He was recognized by the Wall Street Journal and Fortune Magazine as a Wall Street All Star. Prior to that, Ullas received an MBA degree after starting a chemicals trading business in India. He also has a bachelor's degree in organic chemistry. He is also an Angel Investor.
Dave Morin
Investing in BioTech • Energy • A.I. (&...
San Francisco Bay Area, U.S.A.
Previous Investments
• NewCo (Media and Information Services):
$4500000
Dave Morin is a Co-Founder and serves as Partner at Slow Ventures. He previously was Co-Founder and Chief Executive Officer and Director at Path. Morin was a Senior Platform Manager at Facebook and a Mentor at TechStars. Morin is a visionary entrepreneur, technologist, and businessman. Previously, he held positions at Apple, including a Manager of Creation and Collaboration and a Manager of Student Marketing. Morin also founded a design focused technology and internet software company called DM Design Studios in college. He has appeared in publications such as The Economist, Wired, CNN, BusinessWeek, Money, Business 2.0, TechCrunch, CNET, Silicon Alley Insider, The Los Angeles Times, Chicago Tribune, The San Francisco Chronicle, VentureBeat, and others. Morin is a passionate and well received speaker and has delivered keynotes and participated in events worldwide such as South by Southwest, Future of Web Apps, Web 2.0 Expo, Le Web, SNAP Summit, Microsoft MIX, O'Reilly Foo Camp, Facebook f8, and the worldwide syndicate of Facebook Developer Garages. His focus on innovation, vision, and technology strategy has involved extensive interaction with the global market at large. He also serves as a Board Member at Eventbrite and Dwell Media. Morin received a degree in Economics and Business Administration from the University of Colorado at Boulder.
Peter Thiel
Investing in BioTech • FinTech (& Financials...
San Francisco Bay Area, U.S.A.
Previous Investments
• Compass Pathways:
$32590000
• Brave BitGo BitPay:
• Coru:
$7000000 (Series A)
• Compass Therapeutics:
$50000000 (Series A)
• Kreditech:
(Series C)
• Artivest:
$15000000 (Series A)
• Artivest:
$2000000 (Seed Round)
• Earn.com:
$116000000 (Series B)
• Transatomic Power Corporation:
$2500000 (Seed Round)
BioTech • FinTech (& Financials services) • Energy • A.I. (& Big Data) • Aerospace (& Defense)
Description
Peter Thiel is a technology entrepreneur and investor.He first gained attention for innovations in banking and startup finance. Today he is known as the mentor of the PayPal mafia of entrepreneurs, as well as for his warnings of a coming technology deficit with severe economic consequences. He works to accelerate innovation to prevent such a crisis by identifying and funding promising technology ideas and by guiding successful companies to scale and dominate their industries.
In 1998,Thiel made e-commerce easier, faster, and more secure by co-founding and leading PayPal, which now has more than 128 million active financial accounts. In 2002, he sold PayPal to eBay and founded a global macro fund, Clarium.In 2004, he co-founded Palantir Technologies, which offers platforms for finance companies and intelligence, defense, and law enforcement communities to integrate, visualize, and analyze the world’s information.
In the same year, he made the first outside investment in Facebook, a social networking hub that now has more than a billion million active members. He serves on its board.
Building on his personal success as a venture capital investor, Thiel co-founded and manages Founders Fund, a leading Silicon Valley venture capital fund that has pioneered new methods of venture financing that benefit founders. Through Founders Fund, as well as through his private investing, he has helped the next generation of tech companies, such as SpaceX, LinkedIn, Yelp, RoboteX, and Spotify.
And in 2012 he co-founded Mithril Capital Management, an international technology investment fund.Thiel established and funds the Thiel Foundation, which promotes freedom in all its forms. He sponsors the Committee to Protect Journalists, The Seasteading Institute, and the Human Rights Foundation. He funds the artificial intelligence research of theMachine Intelligence Research Institute.
He also aids work against violence through theOslo Freedom Forum and through the research of philosopher René Girard, which is extended and promulgated by Imitatio. He also promotes better health by funding the longevity research of Dr. Cynthia Kenyon and the SENS Research Foundation.Thiel created the 20 Under 20 Thiel Fellowship, which nurtures the tech visionaries of tomorrow. And he formed Breakout Labs to help independent scientists, engineers, and inventors advance their most radical ideas.
Thiel earned a B.A. in philosophy from Stanford University and a J.D. from Stanford Law School, where he occasionally teaches on globalization and technology and serves on the board of overseers of the Hoover Institution.
His articles have appeared in Policy Review and the Wall Street Journal. He co-produced the film Thank You for Smoking, was rated a master by the United States Chess Federation, and received the Innovation Award from the Economist in 2010. He lives in San Francisco.
Tim Chae
Investing in Software (Web Marketplace Saas..) &b...
Active in fintech, e-sports, marketplaces, cross-border. But always prefer to invest in people who make me become aware about large problems.
Not Interested In
Businesses that are capital intensive prior to launch and especially businesses with long feedback loop cycles (pure hardware, etc.)
Partner at @500startups and heading up our $15M Korea specific fund, 500 Kimchi. Started a couple co's (bootstrapped & venture). Big fan of #ELaMF and #JFDI.
Michael Dempsey
Investing in Software (Web Marketplace Saas..) &b...
Jerry Yang serves as Founding Partner at AME Cloud Ventures. Yang also serves as Special Partner at Neotribe Ventures. He serves as Investor of BirdEye. He also serves as an Independent Director at Workday and Advisor at Radius. He is the Founding Partner at AME Cloud Ventures. He serves as Board Observer and Senior Advisor at Didi Kuaidi. Since March 2012, he has worked with and invests in technology entrepreneurs as the founding partner of AME Cloud Ventures, his innovation investment firm. He is also a co-founder of Yahoo! Inc., where he served as a director from March 1995 to January 2012, and as Chief Executive Officer from June 2007 to January 2009. He also led Yahoo!'s investments in Yahoo Japan and Alibaba Group Holding Limited, and he is a currently a director of Alibaba Group, where he has served on the board from October 2005 to January 2012 and from September 2014 to the present. He is also a director of Lenovo, Inc. where he has served on the board since November 2014. From July 2000 to November 2012, he was a member of Cisco Systems, Inc.'s Board of Directors, and he was a director of Yahoo! Japan from January 1996 to January 2012. He also is a director of various private companies and foundations. He received a B.S. and M.S. in Electrical Engineering from Stanford University, where he served as Vice Chair of the Board of Trustees from June 2005 until September 2016. He is also an Angel Investor. He serves as Board Member at Docker
Tony Corbin
Investing in BioTech • Businesses Solutions ...
Menlo Park , San Fran..., U.S.A. - Israel - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Icelan
Previous Investments
• Vayyar Imaging:
$109000000 (Later stage VC)
• VDOO:
$57000000 (Later stage VC)
• Cloudleaf:
$26000000 (Later stage VC)
• Fakespot:
(Series A)
• Fakespot:
$4000000 (Series A)
• Sumatra:
$2000000 (Seed)
• MRGN:
(Pre Seed)
• MRGN:
(Pre-Seed)
• Ash Wellness:
$3000000 (Seed)
• Ash Wellness:
(Seed+)
• AppliedXL:
$4000000 (Seed)
• AssetDash:
(Pre Seed)
• Tabula:
$3000000 (Pre Seed)
• Naya:
$6000000 (Seed)
• Thorium Data:
$100000 (Pre Seed)
• OpenAxis:
$2000000 (Pre Seed)
• CACTIVATE:
(Pre Seed)
• Grin Gaming:
(Seed)
• Grin Gaming:
(Seed)
• Docket:
(Seed)
• Ask Vera:
(Seed)
• UrsaLeo:
(Seed+)
• Cactivate:
(Pre-Seed)
• Clearforce:
(Seed)
• Paragon Intel:
(Seed+)
• Intrro:
(Seed)
• Bazze:
(Pre-Seed)
• Asset Dash:
(Pre-Seed)
• Extend:
$16000000 (Series A)
• OneCell Diagnostics:
$16000000 (Series A)
• Finicast:
$13000000 (Seed)
• Very Good Ventures:
$3000000 (Series A)
• Very Good Ventures:
$3000000 (Series A)
• Prellis Biologics:
$35000000 (Series C)
• Prellis Biologics:
$15000000 (Series B)
• Biomason:
$65000000 (Series C)
• Home Delivery Service (HDS Global):
$5000000 (Series Unknown)
• Rizzle:
$17000000 (Convertible Note)
• EnTribe:
$3000000 (Seed)
• Atonarp:
$50000000 (Series D)
• Atonarp:
$2000000 (Series B)
• Atonarp:
$4000000 (Series A)
• Boom Supersonic:
$50000000 (Series C)
• Extend, Inc.:
$16000000 (Series A)
• Quartic.ai:
$2000000 (Seed)
• Globality:
$27000000 (Series B)
• Globality:
$10000000 (Series A)
• BangDB:
(Seed)
• Reaction:
$10000000 (Series A)
• Reaction:
$2000000 (Seed)
• Shipster:
(Seed)
• H2O.ai:
$9000000 (Series A)
• Trove:
$5000000 (Series A)
• FUTR Corp.:
$5000000 (Seed)
• Yellowsmith:
$850000 (Seed)
• Printi:
$1000000 (Series A)
• GoPro:
$88000000 (Series A)
Tony Corbin
Menlo Park - San Francisco Bay Area - California, U.S.A. - Israel - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Icelan
Riverwood Capital is a globally-focused private equity firm that invests in high-growth businesses in the technology and services industries, across a variety of verticals and geographies. Riverwood has offices in Menlo Park, CA and New York, NY and currently has more than 20 investments in North America, Latin America and Asia. The firm's current fund has $780 million of committed capital. The final fund close was in April 2011. Riverwood invests in mid-market technology and technology enabled products and services. The firm defines mid-market as approximately $100-$500 million in revenue for product companies, and approximately $25-$150 million in revenue for software and services. Riverwood occasionally invests outside these ranges. Riverwood invests on a global basis, having already invested in the U.S., Israel, Argentina, Chile, and Brazil. The firm's normal investment size ranges from $25-75 million.
How to connect with Angel Investors in the BioTech industry?
In the BioTech industry, angel investors such as Esther Dyson, Vinod Khosla, and Steve Jurvetson are prominent figures. These investors focus on startups offering innovative solutions in biotechnology, genomics, and medical research. Esther Dyson, an entrepreneur and investor, looks for biotech startups that have the potential to make significant advancements in healthcare and medicine. Vinod Khosla, founder of Khosla Ventures, invests in high-impact biotech companies with disruptive technologies. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups that push the boundaries of biological science and innovation. To connect with these investors, attend biotech conferences, medical expos, and networking events such as BIO International Convention, JP Morgan Healthcare Conference, and SynBioBeta. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your biotech solution addresses key challenges in healthcare and medical research, such as developing new therapies, improving diagnostic accuracy, or advancing genomic research. Highlight any traction you’ve gained, such as partnerships with research institutions, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as licensing, product sales, or research grants, will further strengthen your pitch. Leveraging endorsements or case studies from biotech experts can also enhance your credibility.
Case Studies: Successful Funding Rounds with Angel Investors on Angels Partners
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment Success
